BioNTech SE
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | +107.1% | -14.9% | +344.1% | +3,834.6% | -8.8% | -77.9% | -28.0% | +0.2% | |
| – | +46.9% | +27.1% | +240.8% | +4,809.8% | +2.9% | -80.0% | -9.8% | +13.9% | |
| – | +117.8% | -19.9% | +363.8% | +3,697.9% | -10.9% | -77.5% | -31.4% | -3.2% | |
| – | +67.3% | +58.3% | +184.8% | +47.2% | +61.9% | +16.0% | +26.4% | -10.3% | |
| – | +5.0% | +76.9% | +124.9% | +189.5% | +74.0% | +2.8% | +7.3% | +10.8% | |
| – | +47.7% | +62.6% | +85.3% | +54.6% | +114.1% | +51.2% | +39.4% | -21.6% | |
| – | – | – | – | – | -17.3% | -94.5% | -290.4% | – | |
| – | +172.9% | -4.7% | +10.1% | +202.0% | +181.1% | -50.9% | +69.6% | +3.6% | |
| – | – | – | – | – | -13.9% | -90.8% | -157.1% | – | |
| – | +1,233.3% | -133.3% | – | – | -26.0% | -92.7% | -104.8% | – | |
| – | – | – | – | +67,613.8% | -8.3% | -90.1% | -171.5% | – | |
| – | – | – | – | – | -12.7% | -89.5% | -126.7% | – |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.